Treatment of cognitive impairment in multiple sclerosis

Behavioural Neurology

Volumn 17, Issue 1, 2006, Pages 53-67

  Pierson, Susan H ^a,b   Griffith, Nathan ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cognitive dysfunction; Depression; Disease characteristics; Employment; Executive dysfunction; Fatigue; Multiple sclerosis; Non pharmacologic treatments; Pharmacologic management; Visuospatial perception; Working memory

Indexed keywords

3 AMINOPYRIDINE; ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; ASCORBIC ACID; BETA1A INTERFERON; CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLORAZEPATE; DIAZEPAM; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; FOLIC ACID; GABAPENTIN; GLATIRAMER; INTERFERON BETA SERINE; LAMOTRIGINE; MAGNESIUM; METHYLPHENIDATE; MODAFINIL; OXYBUTYNIN; PEMOLINE; SPASMOLYTIC AGENT; TIZANIDINE; TOLTERODINE; UNINDEXED DRUG; VALPROIC ACID; VITAMIN D;

AMMONIA BLOOD LEVEL; ATTENTION DISTURBANCE; BRAIN DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PARANOIA; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SIDE EFFECT; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 33646563430     PISSN: 09534180     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/545860     Document Type: Review

References (124)

1. Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury, Jama 282 (1999), 974-983.
2. Continuum on multiple sclerosis, Amer Acad Neurol.
3. International classification of functioning, diability, and health. In, Vol. July 3, World Health Organization, 2000.
4. The International Classification of Impairments, Disabilities, and Handicaps (ICIDH), World Health Organization, 1980.
5. Minimal record of disability for multiple sclerosis, in: International Federation of Multiple Sclerosis Societies, National Multiple Sclerosis Society, New York, 1985.
6. National Multiple Sclerosis Society, Project Alliance final report, in: U.S.D.o. Education, (ed.), Rehabilitation Services Administration, 1997.
7. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders, Neurology 50 (1998), 645-651.
8. M.L. Albert, R.G. Feldman and A.L. Willis, The 'subcortical dementia' of progressive supranuclear palsy, J Neurol Neurosurg Psychiatry 37 (1974), 121-130.
9. M.P. Amato, G. Ponziani, G. Pracucci, L. Bracco, G. Siracusa and L. Amaducci, Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up, Arch Neurol 52 (1995), 168-172.
10. M.P. Amato, G. Ponziani, G. Siracusa and S. Sorbi, Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years, Arch Neurol 58 (2001), 1602-1606.
11. D.W. Anderson, J.H. Ellenberg, C.M. Leventhal, S.C. Reingold, M. Rodriguez and D.H. Silberberg, Revised estimate of the prevalence of multiple sclerosis in the United States, Ann Neurol 31 (1992), 333-336.
12. A.A. Argyriou, E. Chroni, A. Koutras, J. Ellul, S. Papapetropoulos, G. Katsoulas, G. Iconomou and H.P. Kalofonos, Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial, Neurology 64 (2005), 26-31.
13. A.D. Baddeley, Working Memory, Oxford University Press, Oxford, 1986.
14. B. Bagert, P. Camplair and D. Bourdette, Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management, CNS Drugs 16 (2002), 445-455.
15. Y. Barak and A. Achiron, Effect of interferon-beta-1b on cognitive functions in multiple sclerosis, Eur Neurol 47 (2002), 11-14.
16. J. Barbizet and E. Cany, Clinical and psychometrical study of a patient with memory disturbances, Int J Neurol 7 (1968), 44-54.
17. M.R. Basso, S. Beason-Hazen, J. Lynn, K. Rammohan and R.A. Bornstein, Screening for cognitive dysfunction in multiple sclerosis, Arch Neurol 53 (1996), 980-984.
18. W.W. Beatty and D.E. Goodkin, Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination, Arch Neurol 47 (1990), 297-301.
19. W.W. Beatty, R.H. Paul, S.L. Wilbanks, K.A. Hames, C.R. Blanco and D.E. Goodkin, Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI), Neurology 45 (1995), 718-723.
20. A.T. Beck and R.A. Steer, Beck Depression Inventory manual, Psychological Corp., San Antonio, TX, 1987.
21. R.H. Benedict, D.A. Carone and R. Bakshi, Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis, J Neuroimaging 14 (2004), 36S-45S.
22. R.H. Benedict, J.S. Fischer, C.J. Archibald, P.A. Arnett, W.W. Beatty, J. Bobholz, G.J. Chelune, J.D. Fisk, D.W. Langdon, L. Caruso, F. Foley, N.G. LaRocca, L. Vowels, A. Weinstein, J. DeLuca, S.M. Rao and F. Munschauer, Minimal neuropsychological assessment of MS patients: a consensus approach, Clin Neuropsychol 16 (2002), 381-397.
23. R.H. Benedict, A. Shapiro, R. Priore, C. Miller, F. Munschauer and L. Jacobs, Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients, Mult Scler 6 (2000), 391-396.
24. J.R. Blair and O. Spreen, Predicting premorbid IQ: A revision of the National Adult Reading Test, Clinical Neuropsychologist (1989), 129-136.
25. J.M. Bruce and P.A. Arnett, Self-reported everyday memory and depression in patients with multiple sclerosis, J Clin Exp Neuropsychol 26 (2004), 200-214.
26. H. Bushke and P.A. Fuld, Evaluating storage, rention, and retrieval in disordered memory and learning, Neurology (1974), 1019-1025.
27. J.A. Cabrera-Gomez, N. Echazabal-Santana, P. Porrero-Martin, C. Valenzuela-Silva, C.A. Rodriguez, I. Fuentes-Suarez, L. Perez-Ruiz, A.M. Ramos-Cedeno and J.A. Cabrera-Nunez, Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis, Rev Neurol 37 (2003), 214-220.
28. N. Carney, R.M. Chesnut, H. Maynard, N.C. Mann, P. Patterson and M. Helfand, Effect of cognitive rehabilitation on outcomes for persons with traumatic brain injury: A systematic review, J Head Trauma Rehabil 14 (1999), 277-307.
29. D.F. Cella, K. Dineen, B. Arnason, A. Reder, K.A. Webster, G. karabatsos, C. Chang, S. Lloyd, J. Steward and D. Stefoski, Validation of the functional assessment of multiple sclerosis quality of life instrument, Neurology 47 (1996), 129-139.
30. D.F. Cella, D.S. Tulsky, G. Gray, B. Sarafian, E. Linn, A. Bonomi, M. Silberman, S.B. Yellen, P. Winicour, J. Brannon et al., The Functional Assessment of Cancer Therapy scale: development and validation of the general measure, J Clin Oncol 11 (1993), 570-579.
31. N.D. Chiaravalloti, H. Demaree, E.A. Gaudino and J. DeLuca, Can the repetition effect maximize learning in multiple sclerosis? Clin Rehabil 17 (2003), 58-68.
32. K.D. Cicerone, C. Dahlberg, K. Kalmar, D.M. Langenbahn, J.F. Malec, T.F. Bergquist, T. Felicetti, J.T. Giacino, J.P. Harley, D.E. Harrington, J. Herzog, S. Kneipp, L. Laatsch and P.A. Morse, Evidence-based cognitive rehabilitation: recommendations for clinical practice, Arch Phys Med Rehabil 81 (2000), 1596-1615.
33. D.C. Clemmons, R.T. Fraser, G. Rosenbaum, E. Getter and E. Johnson, An abbreviated neuropyschological battery in MultipleSclerosis Vocational Rehabilitation: Findings and Implications, Rehabilitation Psychology 49 (2004), 100-105.
34. G. Comi, M. Filippi, V. Martinelli, A. Campi, M. Rodegher, M. Alberoni, G. Sirabian and N. Canal, Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis, J Neurol Sci 132 (1995), 222-227.
35. L. Coulthard-Morris, Clinical and rehabilitation outcome measures, in: Multiple sclerosis: diagnosis, medical management, and rehabilitation, J.S. Burks and K.P. Johnson, eds, Demos, New York, 2000, pp. 221-290.
36. L.M. De Sonneville, J.B. Boringa, I.E. Reuling, R.H. Lazeron, H.J. Ader and C.H. Polman, Information processing characteristics in subtypes of multiple sclerosis, Neuropsychologia 40 (2002), 1751-1765.
37. J. DeLuca, S. Barbieri-Berger and S.K. Johnson, The nature of memory impairments in multiple sclerosis: acquisition versus retrieval, J Clin Exp Neuropsychol 16 (1994), 183-189.
38. J. DeLuca, E.A. Gaudino, B.J. Diamond, C. Christodoulou and R.A. Engel, Acquisition and storage deficits in multiple sclerosis, J Clin Exp Neuropsychol 20 (1998), 376-390.
39. H.A. Demaree, J. DeLuca, E.A. Gaudino and B.J. Diamond, Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation, J Neurol Neurosurg Psychiatry 67 (1999), 661-663.
40. P.M. Doraiswamy, Non-cholinergic strategies for treating and preventing Alzheimer's disease, CNS Drugs 16 (2002), 811-824.
41. S.G. Edwards, C. Liu and L.D. Blumhardt, Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis, Acta Neurol Scand 104 (2001), 214-223.
42. J.S. Fischer, Cognitive Impairment in Mutliple Sclerosis, in: Handbook of Multiple Sclerosis, (3rd ed.), S.D. Cook, ed., Marcel Dekker, Inc., New York, 2001, pp. 233-255.
43. J.S. Fischer, F.W. Foley, J.E. Aikens, G.D. Ericson, S.M. Rao and S. Shindell, What do we really know about cognitive impairment, affectie disorders, and stress in multiple sclerosis? A practitioner's guide, J Neurol Rehab 8 (1994), 151-164.
44. J.S. Fischer, R.L. Priore, L.D. Jacobs, D.L. Cookfair, R.A. Rudick, R.M. Herndon, J.R. Richert, A.M. Salazar, D.E. Goodkin, C.V. Granger, J.H. Simon, J.H. Grafman, M.D. Lezak, K.M. O'Reilly Hovey, K. Perkins, D. Barilla-Clark, M. Schacter, D.W. Shucard, A.L. Davidson, K.E. Wende, D.N. Bourdette and M.F. Kooijmans-Coutinho, Neuropsychological effects of interferon Beta-1a in relapsing multiple sclerosis, Ann Neurol 48 (2000), 885-892.
45. J.S. Fischer, R.A. Rudick, G.R. Cutter and S.C. Reingold, The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment, Mult Scler 5 (1999), 244-250.
46. J.D. Fisk and C.J. Archibald, Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis, J Int Neuropsychol Soc 7 (2001), 363-372.
47. F.W. Foley, W.M. Dince, J.R. Bedell, N.G. LaRocca, R. Kalb, L.S. Caruso, C.R. Smith and Z.M. Shnek, Psychoremediation of communciation skills for cognitively imapred persons with multiple sclerosis, J Neurol Rehab 8 (1994), 165-176.
48. M.F. Folstein, S.E. Folstein and P.R. McHugh, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 12 (1975), 189-198.
49. J. Foong, L. Rozewicz, G. Quaghebeur, C.A. Davie, L.D. Kartsounis, A.J. Thompson, D.H. Miller and M.A. Ron, Executive function in multiple sclerosis. The role of frontal lobe pathology, Brain 120(1) (1997), 15-26.
50. G.M. Franklin, R.K. Heaton, L.M. Nelson, C.M. Filley and C. Seibert, Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis, Neurology 38 (1988), 1826-1829.
51. J.A. Freeman, D.W. Langdon, J.C. Hobart and A.J. Thompson, Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52 (1999), 50-56.
52. S.L. Galetta, C. Markowitz and A.G. Lee, Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review, Arch Intern Med 162 (2002), 2161-2169.
53. E.A. Gaudino, D.A. Pollina and L.B. Krupp, Neuropsychological findings in chronic mental illness, in: Assessment of neuropsychological functions in psychiatric disorders, A. Calev, ed., American Psychiatric Press, Washington, DC, 1999, pp. 281-328.
54. Y. Ge, R.I. Grossman, J.K. Udupa, J.S. Babb, D.L. Kolson and J.C. McGowan, Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis, AJNR Am J Neuroradiol 22 (2001), 470-475.
55. M.W. Geisler, M. Sliwinski, P.K. Coyle, D.M. Masur, C. Doscher and L.B. Krupp, The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis, Arch Neurol 53 (1996), 185-188.
56. A.C. Gilchrist and F.H. Creed, Depression, cognitive impairment and social stress in multiple sclerosis, J Psychosom Res 38 (1994), 193-201.
57. Y.M. Greene, P.N. Tariot, H. Wishart, C. Cox, C.J. Holt, S. Schwid and J. Noviasky, A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments, J Clin Psychopharmacol 20 (2000), 350-356.
58. D.M. Gronwall, Paced auditory serial-addition task: a measure of recovery from concussion, Percept Mot Skills 44 (1977), 367-373.
59. J. Halper, P. Kennedy, C.M. Miller, L. Morgante, M. Namey and A.P. Ross, Rethinking cognitive function in multiple sclerosis: a nursing perspective, J Neurosci Nurs 35 (2003), 70-81.
60. M.A. Hernan, S.S. Jick, G. Logroscino, M.J. Olek, A. Ascherio and H. Jick, Cigarette smoking and the progression of multiple sclerosis, Brain 128 (2005), 1461-1465.
61. C.I. Higginson, P.A. Arnett and W.D. Voss, The ecological validity of clinical tests of memory and attention in multiple sclerosis, Arch Clin Neuropsychol 15 (2000), 185-204.
62. S.K. Johnson, G. Lange, J. Deluca, L.R. Korn and B. Natelson, The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis, and depression, Appl Neuropsychol 4 (1997), 145-153.
63. A. Jonsson, E.M. Korfitzen, A. Heltberg, M.H. Ravnborg and E. Byskov-Ottosen, Effects of neuropsychological treatment in patients with multiple sclerosis, Acta Neurol Scand 88 (1993), 394-400.
64. P. Kajula, R. Portin and J. Ruutianinen, The progress of conitive decline in multiple sclerosis: a controlled 3 year follow-up, Brain 120 (1997), 289-297.
65. D. Kidd, F. Barkhof, R. McConnell, P.R. Algra, I.V. Allen and T. Revesz, Cortical lesions in multiple sclerosis, Brain 122(1) (1999), 17-26.
66. L.B. Krupp and L.E. Elkins, Fatigue and declines in cognitive functioning in multiple sclerosis, Neurology 55 (2000), 934-939.
67. J. Kulisevsky, Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease, Drugs Aging 16 (2000), 365-379.
68. S. Kumar, Memantine: pharmacological properties and clinical uses, Neurol India 52 (2004), 307-309.
69. J.F. Kurtzke, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology 33 (1983), 1444-1452.
70. N.I. Landro, H. Sletvold and E.G. Celius, Memory functioning and emotional changes in early phase multiple sclerosis, Arch Clin Neuropsychol 15 (2000), 37-46.
71. D.W. Langdonand A.J. Thompson, Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome, Mult Scler 5 (1999), 94-100.
72. N. Larocca, R. Kalb, L. Scheinberg and P. Kendall, Factors associated with unemployment of patients with multiple sclerosis, J Chronic Dis 38 (1985), 203-210.
73. N.G. Larocca, Cognitive and emotional disorders, in: Multiple sclerosis: diagnosis, medical management, and rehabilitation, J. Burks and K.P. Johnson, eds, Demos, New York, 2000, pp. 405-423.
74. N.B. Lincoln, A. Dent, J. Harding, N. Weyman, C. Nicholl, L.D. Blumhardt and E.D. Playford, Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis, J Neurol Neurosurg Psychiatry 72 (2002), 93-98.
75. J. Litvan, J. Grafman, P. Vendrell and J.M. Martinez, Slowed information processing speed in multiple sclerosis, Arch Neurol 45 (1988), 281-285.
76. D.A. Loewenstein, A. Acevedo, S.J. Czaja and R. Duara, Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors, Am J Geriatr Psychiatry 12 (2004), 395-402.
77. V. Mathiowetz, K.M. Matuska and M.E. Murphy, Efficacy of an energy conservation course for persons with multiple sclerosis, Arch Phys Med Rehabil 82 (2001), 449-456.
78. R.J. Mendoza, D.J. Pittenger and C.S. Weinstein, Unit management of depression of patients with multiple sclerosis using cognitive remediation strategies: a preliminary study, Neurorehabil Neural Repair 15 (2001), 9-14.
79. S.L. Minden, E.J. Moes, J. Orav, E. Kaplan and P. Reich, Memory impairment in multiple sclerosis, J Clin Exp Neuropsychol 12 (1990), 566-586.
80. D.C. Mohr, S.L. Hart and A. Goldberg, Effects of treatment for depression on fatigue in multiple sclerosis, Psychosom Med 65 (2003), 542-547.
81. A. Moller, G. Wiedemann, U. Rohde, H. Backmund and A. Sonntag, Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis, Acta Psychiatr Scand 89 (1994), 117-121.
82. T.J. Murray, The psychosocial aspects of multiple sclerosis, Neurol Clin 13 (1995), 197-223.
83. D.L. Nyenhuis, S.M. Rao, J.M. Zajecka, T. Luchetta, L. Bernardin and D.C. Garron, Mood disturbance versus other symptoms of depression in multiple sclerosis, J Int Neuropsychol Soc 1 (1995), 291-296.
84. B.S. Oken, S. Kishiyama, D. Zajdel, D. Bourdette, J. Carlsen, M. Haas, C. Hugos, D.F. Kraemer, J. Lawrence and M. Mass, Randomized controlled trial of yoga and exercise in multiple sclerosis, Neurology 62 (2004), 2058-2064.
85. R.H. Paul, W.W. Beatty, R. Schneider, C.R. Blanco and K.A. Hames, Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance, Appl Neuropsychol 5 (1998), 143-148.
86. R.C. Petersen and E. Kokmen, Cognitive and psychiatric abnormalities in multiple sclerosis, Mayo Clin Proc 64 (1989), 657-663.
87. J.M. Peyser, K.R. Edwards, C.M. Poser and S.B. Filskov, Cognitive function in patients with multiple sclerosis, Arch Neurol 37 (1980), 577-579.
88. J.M. Peyser, S.M. Rao, N.G. LaRocca and E. Kaplan, Guidelines for neuropsychological research in multiple sclerosis, Arch Neurol 47 (1990), 94-97.
89. M.R. Piras, I. Magnano, E.D. Canu, K.S. Paulus, W.M. Satta, A. Soddu, M. Conti, A. Achene, G. Solinas and I. Aiello, Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings, J Neurol Neurosurg Psychiatry 74 (2003), 878-885.
90. N.H. Pliskin, D.P. Hamer, D.S. Goldstein, V.L. Towle, A.T. Reder, A. Noronha and B.G. Arnason, Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b, Neurology 47 (1996), 1463-1468.
91. L.A. Pompeii, S.D. Moon and D.C. McCrory, Measures of physical and cognitive function and work status among individuals with multiple sclerosis: a review of the literature, J Occup Rehabil 15 (2005), 69-84.
92. M. Prosiegel and C. Michael, Neuropsychology and multiple sclerosis: diagnostic and rehabilitative approaches, J Neurol Sci 115(Suppl) (1993), S51-S54.
93. K.W. Rammohan, J.H. Rosenberg, D.J. Lynn, A.M. Blumenfeld, C.P. Pollak and H.N. Nagaraja, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, J Neurol Neurosurg Psychiatry 72 (2002), 179-183.
94. J.J. Randolph, P.A. Arnett and P. Freske, Metamemory in multiple sclerosis: exploring affective and executive contributors, Arch Clin Neuropsychol 19 (2004), 259-279.
95. S.M. Rao, Neuropsychology of multiple sclerosis, Curr Opin Neurol 8 (1995), 216-220.
96. S.M. Rao, Neuropsychology of multiple sclerosis: a critical review, J Clin Exp Neuropsychol 8 (1986), 503-542.
97. S.M. Rao, T.A. Hammeke, M.P. McQuillen, B.O. Khatri and D. Lloyd, Memory disturbance in chronic progressive multiple sclerosis, Arch Neurol 41 (1984), 625-631.
98. S.M. Rao, G.J. Leo, L. Bernardin and F. Unverzagt, Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction, Neurology 41 (1991), 685-691.
99. S.M. Rao, G.J. Leo, L. Ellington, T. Nauertz, L. Bernardin and F. Unverzagt, Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning, Neurology 41 (1991), 692-696.
100. S.M. Rao, G.J. Leo, V.M. Haughton, P. St Aubin-Faubert and L. Bernardin, Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis, Neurology 39 (1989), 161-166.
101. S.M. Rao, P. St Aubin-Faubert and G.J. Leo, Information processing speed in patients with multiple sclerosis, J Clin Exp Neuropsychol 11 (1989), 471-477.
102. P.G. Ritvo, J.S. Fischer, D.M. Miller, H. Andrews, D.W. Paty and N.G. Larocca, Multiple Sclerosis Quality of Life Inventory (MSQLI): a user's manual, National Multiple Sclerosis Society, New York, 1997.
103. D. Rodgers, K. Khoo, M. MacEachen, M. Oven and W.W. Beatty, Cognitive therapy for multiple sclerosis: a preliminary study, Altern Ther Health Med 2 (1996), 70-74.
104. A. Romani, R. Bergamaschi, E. Candeloro, E. Alfonsi, R. Callieco and V. Cosi, Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment, Mult Scler 10 (2004), 462-468.
105. P.M. Rothwell, Quality of life in multiple sclerosis, J Neurol Neurosurg Psychiatry 65 (1998), 433.
106. M. Rovaris, M. Filippi, M. Falautano, L. Minicucci, M.A. Rocca, V. Martinelli and G. Comi, Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis, Neurology 50 (1998), 1601-1608.
107. M. Scarrabelotti and M. Carroll, Memory dissociation and metamemory in multiple sclerosis, Neuropsychologia 37 (1999), 1335-1350.
108. M.T. Schultheis, E. Garay, S.R. Millis and J. Deluca, Motor vehicle crashes and violations among drivers with multiple sclerosis, Arch Phys Med Rehabil 83 (2002), 1175-1178.
109. C.E. Schwartz, L. Coulthard-Morris and Q. Zeng, Psychosocial correlates of fatigue in multiple sclerosis, Arch Phys Med Rehabil 77 (1996), 165-170.
110. S.R. Schwid, M. Covington, B.M. Segal and A.D. Goodman, Fatigue in multiple sclerosis: current understanding and future directions, J Rehabil Res Dev 39 (2002), 211-224.
111. L.J. Scott and D.P. Figgitt, Mitoxantrone: a review of its use in multiple sclerosis, CNS Drugs 18 (2004), 379-396.
112. R.C. Smits, H.H. Emmen, F.W. Bertelsmann, B.M. Kulig, A.C. van Loenen, C.H. Polman, The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study, Neurology 44 (1994), 1701-1705.
113. M.M. Sohlberg and C.A. Mateer, Cognitive rehabilitation: an integrative neuropsychological approach, (2nd ed.), Guilford Press, New York, 2001.
114. A. Solari, A. Motta, L. Mendozzi, E. Pucci, M. Forni, G. Mancardi and C. Pozzilli, Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial, J Neurol Sci 222 (2004), 99-104.
115. B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki and M. Clanet, Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study, Neurology 64 (2005), 1139-1143.
116. M.J.L. Sullivan, E. Dehoux and D.C. Buchanan, An approach to cognitive rehabilitation in multiple sclerosis, Canadian J Rehab 3 (1989), 77-85.
117. N. Tesar, U. Baumhackl, M. Kopp and V. Gunther, Effects of psychological group therapy in patients with multiple sclerosis, Acta Neurol Scand 107 (2003), 394-399.
118. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork and L. Bo, Axonal transection in the lesions of multiple sclerosis, N Engl J Med 338 (1998), 278-285.
119. B.G. Vickrey, R.D. Hays, B.J. Genovese, L.W. Myers and G.W. Ellison, Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis, J Clin Epidemiol 50 (1997), 557-569.
120. B.G. Vickrey, R.D. Hays, R. Harooni, L.W. Myers and G.W. Ellison, A health-related quality of life measure for multiple sclerosis, Qual Life Res 4 (1995), 187-206.
121. A. Weinstein, S.R. Schwid, R.B. Schiffer, M.P. McDermott, D.W. Giang and A.D. Goodman, Neuropsychologic status in multiple sclerosis after treatment with glatiramer, Arch Neurol 56 (1999), 319-324.
122. H. Wishart and D. Sharpe, Neuropsychological aspects of multiple sclerosis: a quantitative review, J Clin Exp Neuropsychol 19 (1997), 810-824.
123. H.A. Wishart, A.J. Saykin, B.C. McDonald, A.C. Mamourian, L.A. Flashman, K.R. Schuschu, K.A. Ryan, C.E. Fadul and L.H. Kasper, Brain activation patterns associated with working memory in relapsing-remitting MS, Neurology 62 (2004), 234-238.
124. K.M. Yorkston, K. Johnson, E.R. Klasner, D. Amtmann, C.M. Kuehn and B. Dudgeon, Getting the work done: a qualitative study of individuals with multiple sclerosis, Disabil Rehabil 25 (2003), 369-379.